Current prescription pattern of maintenance treatments for XXXX @entity1 in Korea: A focus on the transition from acute treatments.

@entity1 @entity162 @entity1092 @entity1770 @entity1316 @entity1091 @entity752 @entity1037 @entity2812 @entity1089 @entity1090
AIMS: We examined prescription patterns in maintenance treatment for recovered @entity162 @entity1 and compared these with acute treatments. METHODS: Using retrospective methods, the @entity162 @entity1 in clinical recovery (Clinical Global Impression Bipolar Version score    <=   2 for 6 months) after acute episode were selected. We reviewed differences between prescription patterns at remission and after a maintenance period of at least 6 months. RESULTS: A total of 340 @entity162 @entity1 were selected. During the maintenance period, more than half of the @entity1 (192, 56.5%) took a @entity1316 ( @entity1316 )   +   antipsychotic (AP) combination. Among the @entity1316 , @entity1092 (149, 43.8%) was most prescribed, and @entity1091 (98, 28.8%) was second, but as @entity1 moved into maintenance treatment, @entity1091 use decreased, and the use of @entity2812 (86, 25.3%) increased. Preferred AP were @entity1089 (125, 36.8%), @entity1770 (67, 19.7%), @entity1090 (48, 14.1%), and @entity1037 (39, 11.5%). The use of @entity1037 in maintenance was greatly decreased compared with that during acute treatment (67, 19.7%). Most @entity1 did not take an antidepressant (AD), but the proportion using one or more AD was increased during maintenance (17.9% to 30.3%), and @entity752 (28, 8.2%) was the preferred AD. Doses were decreased in all drugs, but @entity2812 was maintained at a dose of 133.2        68.5   mg/day. CONCLUSIONS: The most common prescription combination for @entity162 maintenance treatment was @entity1316   +   AP. The use of AP was decreased, whereas the use of AD in combination with @entity1316 and/or AP was increased. The doses of @entity1316 and AP were generally decreased during the maintenance periods, with the exception of @entity2812 .
